Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of treatment with 24 weeks nitazoxanide monotherapy on
end of treatment virologic response, sustained virologic response, reduction of quantitative
serum HCV RNA, changes in ALT and safety parameters.